Trends in Pharmacological Sciences
The TREK K2P channels and their role in general anaesthesia and neuroprotection
Section snippets
Molecular and functional properties of TREK-1
The class of mammalian K2P channel subunits, comprising four transmembrane segments and two pore (P) domains in tandem, includes 15 members 4, 15 (Figure 1 and Figure 2a). The P domains are part of the K+ conduction pathway [16]. Functional K2P channels are dimers of subunits and heteromultimerization occurs 17, 18. Although the 2P-domain K+ channel subunits display the same structural motif, they share only moderate sequence homology outside their P regions [4] (Figure 1).
Human TREK-1 mRNA is
Opening of TREK-1 by volatile general anaesthetics
TREK-1 and its functional homologue TREK-2 are opened by the volatile anaesthetics chloroform, diethyl ether, halothane and isoflurane in transfected mammalian cells 3, 10, 22 (Figure 2b). Opening of these channels by these anaesthetics induces cell hyperpolarization (Figure 2c). Interestingly, the other structurally and functionally related 2P-domain K+ channel TRAAK (Figure 1) is insensitive to volatile anaesthetics [3]. In excised outside-out patches, mouse TREK-1 channel is reversibly
Opening of TREK-1 by gaseous anaesthetics
Nitrous oxide and xenon are known for their potent analgesic action, in addition to their euphoric and neuroprotective effects, and have been shown to inhibit the NMDA receptor 41, 42. Recently, it was demonstrated that clinical concentrations of nitrous oxide and xenon also open TREK-1, further suggesting that this K+ channel might have a role in the general anaesthesia and neuroprotection [11] caused by these agents. In the presence of anaesthetic concentrations that are similar to MAC
Opening of TREK-1 by non-volatile anaesthetics
Chloral hydrate (CH) is used clinically as a sedative in pediatric patients and as an anaesthetic in laboratory animals. It is rapidly metabolised to trichloroethanol (TCE) within minutes of administration and the pharmacological effect of CH is attributed to TCE [12]. Recently, both CH and TCE, at pharmacologically relevant concentrations, were shown to open TREK-1 and TRAAK [12]. CH produced a transient activation of TREK-1, whereas TRAAK exhibited no desensitization. The C-terminal domain of
In vivo evidence for a key role for TREK-1 in general anaesthesia
Riluzole has been shown to enhance the anaesthetic potencies of both isoflurane [43] and halothane [44], which suggest that TREK channels might be involved in anaesthesia. However, these data are difficult to interpret in molecular terms because the enhancement of anaesthetic potency by specific activators or inhibitors (which are often not as selective as supposed) might be due to effects on parallel pathways that are not involved in the actions of the anaesthetic in question.
Very recently,
Lipids, TREK-1 and neuroprotection
PUFAs, including linolenate (LIN) (C18:3), which is found in high quantities in vegetable oils, protect the rat brain against global ischaemia [52] (Figure 3a,b). By contrast, the saturated fatty acid palmitate (PAL) is not neuroprotective (Figure 3b). LIN is protective when administered either intracerebroventricularly or intravenously [52]. LIN also prevents neuronal cell death and paraplegia after transient spinal cord ischaemia in rats [53]. Neuroprotection by LIN, unlike PAL, has also been
Concluding remarks
There is mounting evidence that TREK-1 has an important role in the induction of general anaesthesia for several simple anaesthetics, with the recent data on TREK-1 knockout mice proving to be the most definitive, at least for the volatile agents. Moreover, opening of TREK-1 is clearly important to protect neurons against both ischaemic and epileptic insults. As new K2P channel transgenic animals become available, the roles that other members of this intriguing family of ion channels have in
Acknowledgements
We would like to apologize to all colleagues whose work and reviews could not be acknowledged owing to text and citation limitations. E.H. thanks M. Lazdunski and A.J. Patel for stimulating discussion and continual support. E.H. is funded by the CNRS and the Foundation Paul Hamel and N.P.F. thanks the Medical Research Council (UK) and Carburos Metálicos for support. We also thank Alistair Mathie and Stephen Brickley for helpful comments on the manuscript.
References (65)
- et al.
Properties and modulation of mammalian 2P domain K+ channels
Trends Neurosci.
(2001) Fatty acid-sensitive two-pore domain K+ channels
Trends Pharmacol. Sci.
(2003)Human TREK2, a 2P domain mechano-sensitive K+ channel with multiple regulations by polyunsaturated fatty acids, lysophospholipids, and Gs, Gi, and Gq protein-coupled receptors
J. Biol. Chem.
(2000)- et al.
Trichloroethanol enhances the activity of recombinant human TREK-1 and TRAAK channels
Neuropharmacology
(2004) - et al.
Formation of functional heterodimers between the TASK-1 and TASK-3 two pore domain potassium channel subunits
J. Biol. Chem.
(2002) K+-dependent cerebellar granule neuron apoptosis: role of TASK leak K+ channels
J. Biol. Chem.
(2003)Distribution analysis of human two pore domain potassium channels in tissues of the central nervous system and periphery
Brain Res. Mol. Brain Res.
(2001)Distribution and expression of TREK-1, a two-pore-domain potassium channel, in the adult rat CNS
Neuroscience
(2001)Molecular basis of the voltage-dependent gating of TREK-1, a mechano- sensitive K+ channel
Biochem. Biophys. Res. Commun.
(2002)TRAAK is a mammalian neuronal mechano-gated K+ channel
J. Biol. Chem.
(1999)
Lipid and mechano-gated 2P domain K+ channels
Curr. Opin. Cell Biol.
Mechano- or acid stimulation, two interactive modes of activation of the TREK-1 potassium channel
J. Biol. Chem.
Lysophospholipids open the two P domain mechano-gated K+ channels TREK-1 and TRAAK
J. Biol. Chem.
The neuroprotective agent sipatrigine (BW619C89) potently inhibits the human tandem pore-domain K+ channels TREK-1 and TRAAK
Brain Res.
An ACTH- and ATP-regulated background K+ channel in adrenocortical cells is TREK-1
J. Biol. Chem.
TREK-1 regulation by nitric oxide and cGMP-dependent protein kinase
J. Biol. Chem.
Modulation of TASK-1 (Kcnk3) and TASK-3 (Kcnk9) potassium channels: volatile anesthetics and neurotransmitters share a molecular site of action
J. Biol. Chem.
Functional characterization of human TASK-3, an acid-sensitive two-pore domain potassium channel
Neuropharmacology
Linolenic acid prevents neuronal cell death and paraplegia after transient spinal cord ischemia in rats
J. Vasc. Surg.
Polyunsaturated fatty acids induce ischemic and epileptic tolerance
Neuroscience
General anaesthetics action at transmitter-gated inhibitory amino acid receptors
Trends Pharmacol. Sci.
Selective actions of volatile general anaesthetics at molecular and cellular levels
Br. J. Anaesth.
General anaesthetics hyperpolarize neurons in the vertebrate central nervous system
Science
Volatile general anaesthetics activate a novel neuronal K+ current
Nature
Inhalational anaesthetics activate two-pore-domain background K+ channels
Nat. Neurosci.
Molecular and functional properties of two-pore-domain potassium channels
Am. J. Physiol. Renal Physiol.
Potassium leak channels and the KCNK family of two-P-domain subunits
Nat. Rev. Neurosci.
Two-pore-Domain (KCNK) potassium channels: dynamic roles in neuronal function
Neuroscientist
Update on tandem pore 2P domain K+ channels
Curr. Drug Targets
Two-pore-domain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane
Mol. Pharmacol.
Anesthetic-sensitive 2P domain K+ channels
Anesthesiology
TREK-1, a K+ channel involved in neuroprotection and general anesthesia
EMBO J.
Cited by (184)
Neurobiological basis of emergence from anesthesia
2024, Trends in NeurosciencesSerotonin and consciousness – A reappraisal
2022, Behavioural Brain ResearchA protet-based, protonic charge transfer model of energy coupling in oxidative and photosynthetic phosphorylation
2021, Advances in Microbial PhysiologyA regulatory domain in the K<inf>2P</inf>2.1 (TREK-1) carboxyl-terminal allows for channel activation by monoterpenes
2020, Molecular and Cellular Neuroscience